BIO vs. TMO
Compare and contrast key facts about Bio-Rad Laboratories, Inc. (BIO) and Thermo Fisher Scientific Inc. (TMO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIO or TMO.
Key characteristics
| BIO | TMO | |
|---|---|---|
| YTD Return | -13.34% | 7.91% |
| 1Y Return | -39.51% | 5.18% |
| 3Y Return (Ann) | -22.39% | 7.41% |
| 5Y Return (Ann) | -1.92% | 15.77% |
| 10Y Return (Ann) | 8.48% | 17.87% |
| Sharpe Ratio | -1.18 | 0.20 |
| Daily Std Dev | 33.67% | 21.28% |
| Max Drawdown | -76.26% | -71.16% |
| Current Drawdown | -66.11% | -13.74% |
Fundamentals
| BIO | TMO | |
|---|---|---|
| Market Cap | $7.89B | $218.95B |
| EPS | -$21.83 | $15.60 |
| PE Ratio | 31.53 | 36.77 |
| PEG Ratio | 1.19 | 2.81 |
| Revenue (TTM) | $2.67B | $42.49B |
| Gross Profit (TTM) | $1.57B | $19.00B |
| EBITDA (TTM) | $511.60M | $10.78B |
Correlation
The correlation between BIO and TMO is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BIO vs. TMO - Performance Comparison
In the year-to-date period, BIO achieves a -13.34% return, which is significantly lower than TMO's 7.91% return. Over the past 10 years, BIO has underperformed TMO with an annualized return of 8.48%, while TMO has yielded a comparatively higher 17.87% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BIO vs. TMO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BIO vs. TMO - Dividend Comparison
BIO has not paid dividends to shareholders, while TMO's dividend yield for the trailing twelve months is around 0.25%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIO Bio-Rad Laboratories, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TMO Thermo Fisher Scientific Inc. | 0.25% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% | 0.48% | 0.54% |
Drawdowns
BIO vs. TMO - Drawdown Comparison
The maximum BIO drawdown since its inception was -76.26%, which is greater than TMO's maximum drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for BIO and TMO. For additional features, visit the drawdowns tool.
Volatility
BIO vs. TMO - Volatility Comparison
Bio-Rad Laboratories, Inc. (BIO) has a higher volatility of 10.53% compared to Thermo Fisher Scientific Inc. (TMO) at 7.12%. This indicates that BIO's price experiences larger fluctuations and is considered to be riskier than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BIO vs. TMO - Financials Comparison
This section allows you to compare key financial metrics between Bio-Rad Laboratories, Inc. and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities